Healthcare
Updated Pediatric and Neonatal CPR Guidelines Emphasize Unique Needs of Children
The American Heart Association and American Academy of Pediatrics have released updated CPR and emergency cardiovascular care guidelines that provide specific recommendations for infants and children, addressing the approximately 27,000 pediatric cardiac arrests occurring annually in the United States.
Ethema Health to Acquire Addiction Recovery Care Assets in Kentucky, Creating Statewide Treatment Network
Ethema Health Corporation's planned acquisition of Addiction Recovery Care assets in Kentucky represents a major consolidation in the behavioral healthcare sector that could create a comprehensive statewide treatment network with projected revenues exceeding $125 million in 2026.
Oncotelic Therapeutics Announces Three Abstracts on Deciparticle Everolimus Accepted for 2025 San Antonio Breast Cancer Symposium
Oncotelic Therapeutics will present three abstracts on its investigational intravenous Deciparticle everolimus at the 2025 San Antonio Breast Cancer Symposium, highlighting potential improvements over existing mTOR inhibitors for metastatic breast cancer treatment.
NanoViricides Reports NV-387 Shows Strong Antiviral Activity Against Measles in Preclinical Studies
NanoViricides' clinical lead drug candidate NV-387 demonstrated potent antiviral effects against Measles virus with significant lung protection and extended survival in animal models, potentially offering the first approved treatment for a disease that currently has no specific antiviral therapy.
Medicaid Shouldered Over Half of Firearm Injury Treatment Costs, Study Reveals
A new study shows Medicaid was billed for more than half of firearm injury treatment costs in America, highlighting the financial burden on public healthcare systems as safety-net hospitals struggle with emergency care funding.
AI-Driven Imaging Technology Targets Breast Cancer Detection Challenges in High-Growth Market
Artificial intelligence is transforming breast cancer detection by addressing limitations in traditional imaging methods, particularly for women with dense breast tissue, as companies develop advanced diagnostic solutions for a market facing significant patient demand.
Datavault AI and Wellgistics Health Partner to Integrate Blockchain Technology for Prescription Drug Tracking
Datavault AI and Wellgistics Health are collaborating to integrate blockchain-enabled PharmacyChain smart contract technology into pharmaceutical distribution, aiming to enhance prescription tracking efficiency, transparency, and patient safety while exploring a revenue-sharing model.
AXIM Biotechnologies Secures Exclusive South Korean Distribution for TearScan Diagnostic Tests
AXIM Biotechnologies has partnered with VisionPlus Corp. to exclusively distribute its TearScan diagnostic tests in South Korea, expanding access to advanced ocular diagnostics in a market experiencing rising dry eye disease cases.
Inaugural Jack Sarver Prizes Awarded to St. Louis and Dallas Researchers for Cardiovascular Disease Prevention Studies
Two scientists from Washington University and UT Southwestern received the first Jack Sarver Prizes for research addressing maternal mortality in Nigeria through aspirin prophylaxis and identifying genetic mechanisms linking liver disease to atherosclerosis.
Superior Insurance Advisors Launches Midwest Recovery Drive for $600 Billion Pharma Fund
Superior Insurance Advisors has initiated a Midwest-wide campaign to help employers claim reimbursements from the Department of Justice's $600 billion Pharma Overcharge Recovery Fund, addressing systemic drug pricing issues with critical November 2025 and January 2026 deadlines.
ADAP Advocacy Launches Commercial Targeting Excessive CEO Pay at 340B Hospitals
ADAP Advocacy's new commercial campaign highlights how excessive executive compensation at 340B-eligible hospitals, funded by a program designed to help low-income patients, creates disparities between CEO pay and patient medical debt.
Maris Grove Senior Living Community Demonstrates Value of Comprehensive Transition Support
Erickson Senior Living's Maris Grove community showcases how personalized tours, priority list benefits, and resident support systems create successful transitions to senior living while highlighting the financial and emotional value of community belonging.
Erickson Senior Living's Linden Ponds Community Demonstrates Value of Immersive Exploration in Senior Housing Decisions
Linden Ponds' comprehensive approach to prospective resident engagement showcases how immersive campus experiences and pressure-free exploration help seniors make informed decisions about senior living communities.
Senior Living Decisions Emphasize Personal Experience Over Proximity to Family
A New Jersey couple's experience choosing a retirement community demonstrates how hands-on exploration through tours, overnight stays, and personal consultations helps seniors make informed decisions about their living arrangements.
Greenspring Retirement Community Emphasizes Pressure-Free Exploration for Prospective Residents
Greenspring, an Erickson Senior Living community in Springfield, Virginia, offers multiple personalized approaches for prospective residents to explore the campus without pressure, helping them make informed decisions about senior living options.
Fox Run's Priority List Program Offers Personalized Path to Senior Living Decisions
Erickson Senior Living's Fox Run community provides multiple engagement opportunities through its Priority List program, allowing prospective residents to thoroughly evaluate the community before committing through events, overnight stays, and direct resident interactions.
Izotropic Corp. Advances Breast CT Technology to Address Critical Gaps in Cancer Screening
Izotropic Corporation is developing compression-free 3D breast CT imaging technology to overcome limitations in current screening methods, particularly for women with dense breast tissue, during Breast Cancer Awareness Month.
DeBerard Family Foundation and United Way Partner for Okeechobee Halloween Community Event
The DeBerard Family Foundation and United Way of St. Lucie & Okeechobee are hosting a free Halloween extravaganza that provides safe family entertainment while supporting Healthy Start of Okeechobee's vital community services.
Branded Legacy Advances FDA Pathway for Low-Cost Intranasal Naloxone Alternative
Branded Legacy's subsidiary BioLegacy Evaluative Group is preparing FDA submission materials for a proprietary intranasal naloxone spray that aims to replicate Narcan's performance while reducing costs and improving global accessibility to opioid overdose reversal medication.
Study Finds mRNA COVID Vaccine May Enhance Cancer Immunotherapy Effectiveness
New research presented at the European Society for Medical Oncology conference suggests mRNA coronavirus vaccines could potentially boost the effectiveness of cancer immunotherapy treatments.
Izotropic Corporation Featured in Editorial on AI-Driven 3D Imaging for Breast Cancer Detection
Izotropic Corporation's inclusion in a NetworkNewsWire editorial highlights how the company's AI-powered 3D breast imaging technology addresses critical detection challenges in the growing $9 billion medical imaging market.
Updated CPR Guidelines Introduce Major Changes to Choking Response and Opioid Overdose Treatment
The American Heart Association's 2025 CPR guidelines introduce significant updates including new choking protocols for all ages, expanded opioid overdose response with naloxone guidance, and a unified chain of survival system that could improve survival rates for the 350,000 annual out-of-hospital cardiac arrests in the U.S.
Patented Laonson Pill Cutter Launches Globally on Kickstarter with Automatic Center-Aligning Technology
The Laonson Pill Cutter introduces patented automatic center-aligning technology that ensures precise medication division, addressing a critical healthcare need for accurate dosing across personal and professional settings.
Escondido Infant with Down Syndrome Competes in National Baby Contest to Raise Awareness and Funds for Medical Care
Stevie Gonzales, an Escondido baby born with Down Syndrome and a heart condition, is competing in the national Baby of the Year contest to raise awareness about congenital conditions and secure funding for critical medical treatments and developmental resources.
Dr. Robert J. Rosen Earns 27th Consecutive Castle Connolly Top Doctor Recognition
Dr. Robert J. Rosen's 27th consecutive Top Doctor designation highlights sustained excellence in interventional radiology and the growing importance of minimally invasive vascular treatments for complex conditions affecting patients worldwide.
Bobbie Bennett's Widowhood Memoir Achieves Bestseller Status, Offering Resilience Guide for Life After Loss
Award-winning author Bobbie Bennett's latest book 'Widowhood, The Next Chapter: I'm Still Here - Now What?' has reached bestseller status, providing a transformative perspective on navigating loss and finding renewal that resonates with readers facing similar life transitions.
AI-Enhanced 3D Imaging Technologies Transform Breast Cancer Detection in $9 Billion Market
Artificial intelligence is revolutionizing breast cancer diagnostics through advanced 3D imaging technologies that improve detection accuracy, particularly for women with dense breast tissue, addressing a critical global health challenge affecting millions of women annually.
Oncotelic's 20nm Nanoparticle Technology Enters Human Trials for Enhanced Breast Cancer Treatment
Oncotelic Therapeutics has begun human trials for its 20nm nanoparticle formulation of Everolimus, representing a significant advancement in cancer drug delivery that could dramatically improve tumor targeting and treatment efficacy.
AI-Enhanced 3D Imaging Technology Poised to Transform Breast Cancer Detection in $9 Billion Market
Artificial intelligence is revolutionizing breast cancer diagnostics through advanced 3D imaging technologies that offer improved detection accuracy, particularly for women with dense breast tissue, addressing a critical global health challenge affecting millions of women annually.
Oragenics Regains NYSE Compliance Following $16.5 Million Funding Round for Concussion Treatment Development
Oragenics Inc. has regained full compliance with NYSE American listing standards following a successful $16.5 million public offering, securing financial stability to advance its intranasal concussion treatment through critical clinical trials.